In the acutely damaged cochlear explants, the snRNA‐seq analysis showed no significant changes in Xaf1 expression level within the cochlear explants or in HCs of the Neo group (Figure 4A ), but there was a slightly increasing trend in the Neo group.
← all excerpts
Single-Nucleus Transcriptomics Uncovers Xaf1-Driven PANoptosis as a Therapeutic Target in Aminoglycoside-Induced Hearing Loss.
1
—
—